Abstract
Purpose
Multiple endocrine neoplasia Type 2A (MEN2A) can occur with Hirschsprung disease (HD) due to mutation in the RET proto-oncogene, with the majority develo** medullary thyroid carcinoma (MTC). Given the comorbidity, many parents have contacted us to share concerns and unfortunate experiences about the prevalence rates of MEN2A/MTC in patients with HD. The aim is to determine the prevalence rate of patients with HD and MEN2A or medullary thyroid carcinoma, respectively.
Methods
This is a cross-sectional study of the COSMOS database from January 01, 2017, to March 08, 2023. The database was searched for patients diagnosed with MEN2A, MTC, and HD. IRB exemption was provided (COMIRB #23-0526).
Results
The database contained 183,993,122 patients from 198 contributing organizations. The prevalence of HD and MEN2A was 0.00002%, and for HD and MTC was 0.000009%. One in 66 patients (1.5%) with MEN2A also had HD. One in 319 patients (0.3%) in the HD group had MEN2A. One in 839 patients (0.1%) within the HD population had MTC.
Conclusion
The prevalence of MTC and HD or MEN2A and HD in the study population was low. Considering that almost all MEN2A patients have a positive family history, this data does not support the general genetic testing of HD patients.
Similar content being viewed by others
References
Badner JA, Sieber WK, Garver KL, Chakravarti A (1990) A genetic study of Hirschsprung disease. Am J Hum Genet 46:568–580
Moore SW, Zaahl M (2012) The Hirschsprung’s-multiple endocrine neoplasia connection. Clinics 67:63–67. https://doi.org/10.6061/clinics/2012(Sup01)12
Tilghman JM, Ling AY, Turner TN et al (2019) Molecular genetic anatomy and risk profile of Hirschsprung’s disease. N Engl J Med 380:1421–1432. https://doi.org/10.1056/nejmoa1706594
Raue F, Frank-Raue K (2009) Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Hormones 8:23–28. https://doi.org/10.14310/horm.2002.1218
Kloos RT, Eng C, Evans DB et al (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565–612. https://doi.org/10.1089/thy.2008.0403
Bussières V, Roy S, Deladoey J et al (2018) Prophylactic thyroidectomies in MEN2 syndrome: management and outcomes. J Pediatr Surg 53:283–285. https://doi.org/10.1016/j.jpedsurg.2017.11.015
Frank-Raue K, Rybicki LA, Erlic Z et al (2011) Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat 32:51–58. https://doi.org/10.1002/humu.21385
Bütter A, Gagné J, Al-Jazaeri A et al (2007) Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung’s disease. J Pediatr Surg 42:203–206. https://doi.org/10.1016/j.jpedsurg.2006.09.019
Sijmons RH, Hofstra RMW, Wijburg FA et al (1998) Oncological implications of RET gene mutations in Hirschsprung’s disease. Gut 43:542–547. https://doi.org/10.1136/gut.43.4.542
Decker A, Louis S (1998) Occurrence of MEN 2a in familial Hirschsprung’s disease. J Pediatr Surg 33:207–214
Lallier M, St-Vil D, Giroux M et al (1998) Prophylactic thyroidectomy for medullary thyroid carcinoma in gene carriers of MEN2 syndrome. J Pediatr Surg 33:846–848. https://doi.org/10.1016/S0022-3468(98)90656-X
Grubbs EG, Gagel RF (2015) My, how things have changed in multiple endocrine neoplasia type 2A! J Clin Endocrinol Metab 100:2532–2535. https://doi.org/10.1210/jc.2015-2516
Krampitz GW, Norton JA (2014) RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Cancer 120:1920–1931. https://doi.org/10.1002/cncr.28661
Wells SA, Asa SL, Dralle H et al (2015) Revised American thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567–610. https://doi.org/10.1089/thy.2014.0335
Škába R, Dvořáková Š, Václavíková E et al (2006) The risk of medullary thyroid carcinoma in patients with Hirschsprung’s disease. Pediatr Surg Int 22:991–995. https://doi.org/10.1007/s00383-006-1785-6
Vaclavikova E, Dvorakova S, Sykorova V et al (2009) RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest. Endocrine 36:419–424. https://doi.org/10.1007/s12020-009-9242-7
Dvořáková Š, Dvořáková K, Malíková M et al (2005) A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung’s disease. J Pediatr Surg 40:E1–E6. https://doi.org/10.1016/j.jpedsurg.2005.03.031
Vaclavikova E, Kavalcova L, Skaba R et al (2012) Hirschsprung’s disease and medullary thyroid carcinoma: 15-year experience with molecular genetic screening of the RET proto-oncogene. Pediatr Surg Int 28:123–128. https://doi.org/10.1007/s00383-011-2993-2
Pakarinen MP, Rintala RJ, Koivusalo A et al (2005) Increased incidence of medullary thyroid carcinoma in patients treated for Hirschsprung’s disease. J Pediatr Surg 40:1532–1534. https://doi.org/10.1016/j.jpedsurg.2005.05.041
Moore SW, Zaahl MG (2008) Multiple endocrine neoplasia syndromes, children, Hirschsprung’s disease and RET. Pediatr Surg Int 24:521–530. https://doi.org/10.1007/s00383-008-2137-5
Moore SW, Zaahl M (2010) Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 “Janus” genetic variation. J Pediatr Surg 45:393–396. https://doi.org/10.1016/j.jpedsurg.2009.10.080
Acknowledgements
We thank the EPIC COSMOS team, Ryan Prieto and Harry Freedman. Also, thanks to Sara Deakyne Davies, EPIC Superuser at the Children’s Hospital Colorado, for analytical support and critical review of the database data analysis.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wehrli, L.A., Reppucci, M.L., Ketzer, J. et al. Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database. Pediatr Surg Int 39, 227 (2023). https://doi.org/10.1007/s00383-023-05511-0
Accepted:
Published:
DOI: https://doi.org/10.1007/s00383-023-05511-0